CareFusion AirLife Signs New Distribution Agreement with ResMed
AirLife to Offer Nasal High Flow Interfaces from ResMed
Nov 5, 2015
SAN DIEGO, CA, Nov. 5, 2015/PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute innovative nasal high flow interface products from the company.
"This agreement with ResMed is aligned with our commitment to providing high quality respiratory products to our customers," said Dan Woolson, president of Respiratory Solutions at BD. "This collaboration will help ensure our customers have access to a full portfolio of leading respiratory solutions."
The agreement with ResMed includes exclusive distribution rights for its AcuCare™ high flow nasal cannula in the U.S. acute care market. ResMed's nasal cannula offers a fast and intuitive fit, and is engineered to stay in place once fitted, providing speed and stability for built-in success in high flow oxygen therapy.
"The combination of ResMed products with AirLife's reach will help provide more patients with innovative respiratory technology," said Jim Hollingshead, president ResMed Americas. "This collaboration helps position ResMed for growth beyond what we could achieve alone."
Additional terms of the agreement were not disclosed.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit bd.com.
Back to News Releases